UCB to Acquire Candid for up to $2.2B, Expanding Presence in TCE Antibodies for Immunology - Genetic Engineering and Biotechnology News
UCB→Candid Therapeutics
May 6, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
SRX Health Solutions acquisition has completed the acquisition of SRX Health Solutions, a healthcare services other business in Florida, for $0.0001. SRX Health Solutions operates in the healthcare services other segment, supporting healthcare services delivery activities tied to its Florida operations. The healthcare M&A rationale centers on expanding FL acquisitions and strengthening the company’s healthcare services other footprint through an other acquisition structure. The announced other acquisition was structured via a share exchange and asset transfer agreement, with SRX Health Solutions filing an SEC Form S-4/A to register common stock issued under the transaction terms.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
UCB→Candid Therapeutics
May 6, 2026
Pediatrica Health Group→Pediatric practice led by Juan Ruiz-Unger
May 5, 2026
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 5, 2026
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 5, 2026
Xpress Wellness→Midwest Counseling Services
May 5, 2026